Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Thinking Outside Cancer's Box

April 11th 2018, 6:17pm

Article

Cancer is a serious business. But who said it needs to be a business of seriousness?

More May Benefit from PARP Inhibitors Through Drug Combinations

April 10th 2018, 10:00pm

Article

PARP inhibitors are continuing to create buzz in the ovarian cancer space, both as single agents and in combinations that are currently being examined in clinical trials.

FDA Approves Rubraca for Maintenance Ovarian Cancer Treatment

April 6th 2018, 9:43pm

Article

The Food and Drug Administration (FDA) approved Rubraca (rucaparib) as a maintenance therapy for women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy, according to Clovis Oncology, the company that manufactures the drug.

PARP-7 Protein May Significantly Improve Ovarian Cancer Survival

April 5th 2018, 7:23pm

Article

Despite exciting developments of PARP inhibitors over the years, limited knowledge exists in the mechanism of PARP-7 and its potential effect in targeted therapy for patients with ovarian cancer.

Bizarre Coincidence Sparks Oncofertility Conversations

April 3rd 2018, 8:51pm

Article

Following fertility clinic malfunctions in Cleveland and San Francisco, many patients who have or had cancer are facing devastating losses, leaving many questions in the wake of these events.

Only Certain Gynecologic Malignancies Benefit from Immunotherapy

April 2nd 2018, 6:20pm

Article

As checkpoint inhibitors have changed the treatment landscape for many cancers, three specific biomarkers identified a subgroup of women with cervical and ovarian cancer tumor types who may benefit from such therapies.

Opioids Aren't Always the Answer for Certain Post-Op Procedures

March 30th 2018, 6:13pm

Article

As more people in the United States become addicted or face opioid overdoses, health care professionals are starting to take a step back and re-evaluate their prescribing habits.

Women with Recurrent Ovarian Cancer Should Be Screened for Various Biomarkers

March 29th 2018, 10:23pm

Article

Although genomic profiling successfully identifies those with microsatellite instability status who may benefit from PD-1 inhibitor therapy, a vast amount of women may be missed if they are not also tested for high tumor mutation burden too.

Preventing Opioid Addiction in Patients With Cancer

March 28th 2018, 7:57pm

Video

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

Ask an Expert: How Do PARP Inhibitors Work?

March 27th 2018, 7:41pm

Video

PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.